News and Announcements
Universal Biosensors Annual General Meeting Presentation
- Published July 13, 2015 11:03AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
ASX Announcement, 9th July 2015
Key Highlights: last 12 months
Acceleration in revenues from blood glucose monitoring
- Quarterly Services Fees up to $2.9m in Q1 FY’15 (up 142% on pcp)
First strip manufacturing revenues from blood coagulation monitoring
- CE Mark and launch of Siemens Xprecia StrideTM Coagulation Analyzer
- Xprecia StrideTM wins international Red Dot Design Award and Australian Design Award
- Cumulative revenues from PT-INR strip manufacturing of $288K (to 31st March 2015)
Continued leveraged investment in new product development
- Around 70% of R&D investment (last 12 months) funded by partners and R&D Tax Rebates,
- Progressing the expansion of our product portfolio;
– UBI-owned PT-INR test for decentralised and home use
– Further POC coagulation tests for Siemens
– Demonstration of immunoassay platform capability
Revenue growth driving improved financial performance
- Two product revenue streams now in play
- Increasing contribution from Product & Services
- Cash breakeven in sight
To read the full presentation, please click here.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
